ADAM8 as a drug target in pancreatic cancer
Uwe Schlomann(Philipps University of Marburg), Jörg W. Bartsch(Philipps University of Marburg)
Cited by 124
Related Papers
The Metalloprotease-Disintegrin ADAM8 Alters the Tumor Suppressor miR-181a-5p Expression Profile in Glioblastoma Thereby Contributing to Its Aggressiveness
|Frontiers in Oncology|2022|35
Inhibition of Carbonic Anhydrase 2 Overcomes Temozolomide Resistance in Glioblastoma Cells
|International Journal of Molecular Sciences|2021|30
Identification of Dysregulated microRNAs in Glioblastoma Stem-like Cells
|Brain Sciences|2023|8